Share on facebook
Share on twitter
Share on linkedin

July 26, 2013: Plasma Gelsolin Inflammation Patent Granted in Japan, Further Expanding Coverage in Asia

BOSTON MASSACHUSSETTS and MORRISTOWN, NEW JERSEY–(BIOAEGIS THERAPEUTICS – July 26, 2013) BioAegis Therapeutics announced today that a patent has been granted in Japan that that covers the diagnostic claims of the therapeutic and diagnostic application. Further Japanese applications for therapeutic claims in inflammation are pending.